Shield Therapeutics PLC (LON:STX) said Hans-Peter Rudolf is joining Shield's senior executive team as the chief financial officer (CFO) with immediate effect.
Rudolf is a Swiss national with extensive international experience, particularly in the US. At various stages, he has worked for Deloitte, Ernst & Young and as CFO at Vicarius Pharma, a start-up company offering research-driven pharma and biotech companies a platform to build a dedicated European commercial organisation to market and sell their assets through long-term licence and partnership agreements.
“His experience in both public practice and commercial companies and his US experience will be invaluable to Shield, particularly as we scale up activities in the US,” said Tim Watts, the chief executive officer at Shield Therapeutics.